carboxyatractyloside has been researched along with stanozolol in 1 studies
Studies (carboxyatractyloside) | Trials (carboxyatractyloside) | Recent Studies (post-2010) (carboxyatractyloside) | Studies (stanozolol) | Trials (stanozolol) | Recent Studies (post-2010) (stanozolol) |
---|---|---|---|---|---|
261 | 0 | 22 | 580 | 60 | 91 |
Protein | Taxonomy | carboxyatractyloside (IC50) | stanozolol (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.113 | |
Adenosine receptor A3 | Homo sapiens (human) | 8.325 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 9.274 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 1.1276 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.022 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 8.325 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.048 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 8.325 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clark, JD; Hatch, RC; Jain, AV; Weiss, R | 1 |
1 other study(ies) available for carboxyatractyloside and stanozolol
Article | Year |
---|---|
Toxicologic study of carboxyatractyloside (active principle in cocklebur--Xanthium strumarium) in rats treated with enzyme inducers and inhibitors and glutathione precursor and depletor.
Topics: Animals; Atractyloside; Benzoflavones; beta-Naphthoflavone; Cobalt; Cysteine; Glycosides; Kidney Tubules; Lethal Dose 50; Liver; Male; Maleates; Phenobarbital; Phenylbutazone; Piperonyl Butoxide; Plants, Toxic; Rats; Rats, Inbred Strains; Stanozolol | 1982 |